NPI registry status
Active
2026 NPPES data Radiation Oncology Physician NPI 1871595348 M.D.
Verify on CMS → Deborah Butzbach, M.D.
Radiation Oncology Physician in Mount Holly, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,018 in Radiation Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
105
Medicare Part D claims · 51 beneficiaries · Radiation Oncology Physician avg: 186
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.9/100
▼ 3 pts below national avg 83.1 · Above neutral
Industry payments
$16.13
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Deborah Butzbach, M.D. reported a CMS MIPS final score of 79.9/100 - below the 83.1 national average - and filed 105 Medicare Part D claims in 2023.
- 79.9/100
- MIPS score · -3 vs avg
- 105
- Part D claims, 2023
- 76%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Deborah Butzbach, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
80 30th percentile higher than 30% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Deborah Butzbach, M.D. sits
This provider among radiation oncology physician peers
Across the 1,988 radiation oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Deborah Butzbach, M.D. writes more Part D claims than 53% of them and scores higher on MIPS quality than 32% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one radiation oncology physician peer from a representative sample of 60; the gold marker is Deborah Butzbach, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Deborah Butzbach, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Deborah Butzbach, M.D.?
Near national averagePrimary specialty
Radiation Oncology Physician
Medicare Part D claims
105 44% vs specialty avg
MIPS final score
79.9/100 3.2 pts vs avg
Specialty distribution in New Jersey
How Radiation Oncology Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Deborah Butzbach, M.D.'s 2023 MIPS final score plotted against the Radiation Oncology Physician national average
- MIPS Final Score
- 79.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Radiation Oncology Physician) - 79.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Deborah Butzbach, M.D. appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding M.D. credentials at 175 MADISON AVE, Mount Holly, NJ, 08060, with a listed phone of (609) 267-0700. NPI 1871595348 was issued on 08/13/2005.
Medicare Part D records for calendar year 2023 show 105 prescription claims written by this provider, covering 51 Medicare beneficiaries and totaling roughly $2K in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 31.4%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.9/100 for the 2023 performance year (Quality 63.5), compared with the national average of 83.1.
Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1871595348 |
|---|---|
| Specialty | Radiation Oncology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 08/13/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
79.934
Final Score
Avg: 83.1
63.5163
Quality
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Deborah Butzbach, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Clinical Health Care Associates OF New Jersey PC
Mount Holly, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Deborah Butzbach, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$16
Largest payer
Regeneron Healthcare Solutions, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Deborah Butzbach, M.D. - brand share 24.0%
Radiation Oncology Physician average
24% brand-name claims vs 76% generic, on 105 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
105
Total Claims
$2K
Total Drug Cost
51
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 109
- Total Day Supply
- 2,028
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $950
- Generic Drug Cost
- $1K
- Opioid Claims
- 33 (31.4% rate)
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.44
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Deborah Butzbach, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Betamethasone Vale…
Betamethasone Valerate
19 claims
- Tramadol Hcl
Tramadol Hcl
18 claims
- Silver Sulfadiazine
Silver Sulfadiazine
12 claims
| Drug | Claims |
|---|---|
| Betamethasone Valerate | 19 |
| Tramadol Hcl | 18 |
| Silver Sulfadiazine | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Radiation Oncology Physician Overview
How Deborah Butzbach, M.D. fits within the Radiation Oncology Physician landscape nationally.
6,018
Radiation Oncology Physician Providers in US
52
States with Radiation Oncology Physician
186
Avg Claims per Provider
Deborah Butzbach, M.D.'s 105 claims are below the specialty average of 186.
Nearby Radiation Oncology Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Butzbach.
Dr. Arvin Adler
D.O.
Passaic, NJ
Dr. Stuti Ahlawat
MD
Camden, NJ
Dr. Lemuel Ariaratnam
M.D.
Mount Holly, NJ
Dr. Young Bae
M.D.
Toms River, NJ
Dr. Joseph Baron
M.D.
Toms River, NJ
Compare Radiation Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Radiation Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New Jersey
Frequently Asked Questions
What is Deborah Butzbach, M.D.'s specialty? ▼
Deborah Butzbach, M.D. specializes in Radiation Oncology Physician and practices in Mount Holly, New Jersey. Credentials: M.D..
How much does Deborah Butzbach, M.D. prescribe under Medicare Part D? ▼
In 2023, Deborah Butzbach, M.D. wrote 105 Medicare Part D claims totaling $2K in drug costs for 51 beneficiaries.
What is Deborah Butzbach, M.D.'s Medicare quality score? ▼
Deborah Butzbach, M.D. has a CMS MIPS Final Score of 79.9/100 (Quality: 63.5). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Deborah Butzbach, M.D. located? ▼
Deborah Butzbach, M.D. is located at 175 MADISON AVE, Mount Holly, NJ, 08060. Phone: (609) 267-0700.
What is Deborah Butzbach, M.D.'s NPI number? ▼
Deborah Butzbach, M.D.'s National Provider Identifier (NPI) is 1871595348, issued on 08/13/2005.
Does Deborah Butzbach, M.D. prescribe more brand-name or generic drugs? ▼
Deborah Butzbach, M.D.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $950 in brand drug costs.
Does Deborah Butzbach, M.D. prescribe opioids? ▼
Yes, Deborah Butzbach, M.D. had 33 opioid claims in 2023 with an opioid prescribing rate of 31.4%.
How many Radiation Oncology Physician providers are there in the US? ▼
There are 6,018 Radiation Oncology Physician providers across 52 states in the US. The average Radiation Oncology Physician provider writes 186 Medicare Part D claims per year.
What drugs does Deborah Butzbach, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Deborah Butzbach, M.D.'s most frequently prescribed drugs include Betamethasone Valerate, Tramadol Hcl, Silver Sulfadiazine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Deborah Butzbach, M.D. accept Medicare? ▼
Deborah Butzbach, M.D. appears in CMS Medicare data with 105 Part D claims and 51 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Deborah Butzbach, M.D.'s credentials? ▼
Deborah Butzbach, M.D.'s NPI is 1871595348 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.